10-QPeriod: Q1 FY2002

QUEST DIAGNOSTICS INC Quarterly Report for Q1 Ended Mar 31, 2002

Filed May 13, 2002For Securities:DGX

Summary

Quest Diagnostics Incorporated (DGX) reported a strong first quarter for 2002, with net income increasing significantly to $66.7 million from $35.7 million in the same period last year. This substantial growth was driven by a 7.3% increase in net revenues, bolstered by a 4.1% rise in average revenue per requisition and a 2.5% increase in testing volume. The company also benefited from the adoption of SFAS 142, which eliminated goodwill amortization and positively impacted net income by $8.6 million. Operational efficiencies from Six Sigma initiatives and cost savings from the SmithKline Beecham integration further contributed to the improved financial performance. Looking ahead, Quest Diagnostics has made significant strategic moves, including the completion of the American Medical Laboratories, Inc. (AML) acquisition and the pending acquisition of Unilab Corporation. These acquisitions are expected to expand the company's reach and service offerings. The company's financial position remains robust, with healthy operating cash flow and available borrowing capacity to support ongoing growth initiatives and strategic transactions.

Key Highlights

  • 1Net income surged by 86.7% to $66.7 million ($0.67 per diluted share) in Q1 2002, compared to $35.7 million ($0.37 per diluted share) in Q1 2001.
  • 2Net revenues grew 7.3% to $946.8 million, driven by a 4.1% increase in average revenue per requisition and a 2.5% rise in testing volume.
  • 3The adoption of SFAS 142 (effective January 1, 2002) eliminated goodwill amortization, adding $8.6 million to net income for the quarter.
  • 4Operating costs as a percentage of net revenues improved, with Cost of Services decreasing to 58.9% and SG&A expenses decreasing to 27.3%.
  • 5Bad debt expense as a percentage of net revenues improved to 5.8% from 6.3% in the prior year's quarter.
  • 6Net interest expense decreased by $10.0 million due to reduced debt levels and lower interest rates.
  • 7The company completed the acquisition of American Medical Laboratories, Inc. (AML) for approximately $500 million and entered into an agreement to acquire Unilab Corporation.

Frequently Asked Questions

The primary drivers of Quest Diagnostics' significant earnings growth in Q1 2002 were an increase in net revenues driven by improvements in average revenue per requisition and clinical testing volume, along with operational efficiencies from Six Sigma initiatives and cost savings from the integration of SmithKline Beecham Clinical Laboratories. Additionally, the adoption of SFAS 142, which eliminated goodwill amortization, significantly boosted net income.

The adoption of SFAS 142, effective January 1, 2002, eliminated the amortization of goodwill. For the first quarter of 2002, this resulted in a reduction of goodwill amortization expense of $8.6 million (net of taxes), which directly contributed to the reported increase in net income and earnings per share. The company also provided adjusted earnings figures for 2001 to reflect the impact of SFAS 142 retrospectively.

Quest Diagnostics completed the acquisition of American Medical Laboratories, Inc. (AML) and its affiliate LabPortal, Inc. on April 1, 2002, for approximately $500 million. Additionally, on April 2, 2002, the company entered into a definitive agreement to acquire Unilab Corporation, with an expected closing in the second quarter of 2002. These acquisitions are expected to expand the company's market presence and service capabilities.

Quest Diagnostics demonstrated effective cost management in Q1 2002. The cost of services decreased as a percentage of net revenues to 58.9% from 59.9% year-over-year, primarily due to higher average revenue per requisition and Six Sigma efficiencies, despite increases in employee compensation and supply costs. Selling, general, and administrative (SG&A) expenses also decreased as a percentage of net revenues to 27.3% from 28.6%, largely due to improved revenue collection and Six Sigma initiatives, even with higher employee compensation costs. Bad debt expense also improved.